05
Pharmaceutical preparations; pharmaceutical preparations for
injection; pharmaceutical preparation for subcutaneous
injection; pharmaceutical preparations for the treatment of
endocrine diseases and disorders; pharmaceutical
preparations for the treatment of tumours; pharmaceutical
preparations for the treatment of carcinoid tumours;
pharmaceutical preparations comprising peptides for hormonal
treatment and tumour treatment; pharmaceutical preparations
for the treatment of neuroendocrine tumours; pharmaceutical
preparations for the treatment of gastro-enteropancreatic
neuroendocrine tumours; pharmaceutical preparations for the
treatment of gastrointestinal diseases and disorders;
pharmaceutical preparations for gastrointestinal bleeding
disorders; pharmaceutical preparations for the treatment of
gastrointestinal bleeding disorders; pharmaceutical
preparations for the treatment of esophageal bleeding;
pharmaceutical preparations for metabolic disorders;
pharmaceutical preparations for the treatment of acromegaly;
pharmaceutical preparations for the treatment of polycystic
liver disease; pharmaceutical preparations for the treatment
of respiratory diseases or syndrome; pharmaceutical
preparations for the treatment of respiratory distress
syndrome; pharmaceutical preparations for the treatment of
acute respiratory distress syndrome; pharmaceutical
preparations for the treatment of disorders of the autonomic
nervous system; pharmaceutical preparations intended to
block growth hormone
10
Devices for administration of pharmaceuticals for the
treatment of endocrine diseases and disorders; devices for
administration of pharmaceuticals for the treatment of
tumours; devices for administration of pharmaceuticals for
the treatment of carcinoid tumours; devices for
administration of pharmaceuticals comprising peptides for
hormonal treatment and tumour treatment; devices for
administration of pharmaceuticals for the treatment of
neuroendocrine tumours; devices for administration of
pharmaceuticals for the treatment of gastro-enteropancreatic
neuroendocrine tumours; devices for administration of
pharmaceuticals for the treatment of gastrointestinal
diseases and disorders; devices for administration of
pharmaceuticals for gastrointestinal bleeding disorders;
devices for administration of pharmaceuticals for the
treatment of gastrointestinal bleeding disorders; devices
for administration of pharmaceuticals for the treatment of
esophageal bleeding; devices for administration of
pharmaceuticals for metabolic disorders; devices for
administration of pharmaceuticals for the treatment of
acromegaly; devices for administration of pharmaceuticals
for the treatment of polycystic liver disease; devices for
administration of pharmaceuticals for the treatment of
respiratory diseases or syndrome; devices for administration
of pharmaceuticals for the treatment of respiratory distress
syndrome; devices for administration of pharmaceuticals for
the treatment of acute respiratory distress syndrome;
devices for administration of pharmaceuticals for the
treatment of disorders of the autonomic nervous system;
devices for administration of pharmaceuticals intended to
block growth hormone; syringes for administration of
pharmaceuticals for the treatment of endocrine diseases and
disorders; syringes for administration of pharmaceuticals
for the treatment of tumours; syringes for administration of
pharmaceuticals for the treatment of carcinoid tumours;
syringes for administration of pharmaceuticals comprising
peptides for hormonal treatment and tumour treatment;
syringes for administration of pharmaceuticals for the
treatment of neuroendocrine tumours; syringes for
administration of pharmaceuticals for the treatment of
gastro-enteropancreatic neuroendocrine tumours; syringes for
administration of pharmaceuticals for the treatment of
gastrointestinal diseases and disorders; syringes for
administration of pharmaceuticals for gastrointestinal
bleeding disorders; syringes for administration of
pharmaceuticals for the treatment of gastrointestinal
bleeding disorders; syringes for administration of
pharmaceuticals for the treatment of esophageal bleeding;
syringes for administration of pharmaceuticals for metabolic
disorders; syringes for administration of pharmaceuticals
for the treatment of acromegaly; syringes for administration
of pharmaceuticals for the treatment of polycystic liver
disease; syringes for administration of pharmaceuticals for
the treatment of respiratory diseases or syndrome; syringes
for administration of pharmaceuticals for the treatment of
respiratory distress syndrome; syringes for administration
of pharmaceuticals for the treatment of acute respiratory
distress syndrome; syringes for administration of
pharmaceuticals for the treatment of disorders of the
autonomic nervous system; syringes for administration of
pharmaceuticals intended to block growth hormone; pens for
administration of pharmaceuticals for the treatment of
endocrine diseases and disorders; pens for administration of
pharmaceuticals for the treatment of tumours; pens for
administration of pharmaceuticals for the treatment of
carcinoid tumours; pens for administration of
pharmaceuticals comprising peptides for hormonal treatment
and tumour treatment; pens for administration of
pharmaceuticals for the treatment of neuroendocrine tumours;
pens for administration of pharmaceuticals for the treatment
of gastro-enteropancreatic neuroendocrine tumours; pens for
administration of pharmaceuticals for the treatment of
gastrointestinal diseases and disorders; pens for
administration of pharmaceuticals for gastrointestinal
bleeding disorders; pens for administration of
pharmaceuticals for the treatment of gastrointestinal
bleeding disorders; pens for administration of
pharmaceuticals for the treatment of esophageal bleeding;
pens for administration of pharmaceuticals for metabolic
disorders; pens for administration of pharmaceuticals for
the treatment of acromegaly; pens for administration of
pharmaceuticals for the treatment of polycystic liver
disease; pens for administration of pharmaceuticals for the
treatment of respiratory diseases or syndrome; pens for
administration of pharmaceuticals for the treatment of
respiratory distress syndrome; pens for administration of
pharmaceuticals for the treatment of acute respiratory
distress syndrome; pens for administration of
pharmaceuticals for the treatment of disorders of the
autonomic nervous system; pens for administration of
pharmaceuticals intended to block growth hormone; devices
for subcutaneous administration of pharmaceuticals; devices
for parenteral administration of pharmaceuticals; devices
for injection of pharmaceutical depots; devices for
subcutaneous injection of pharmaceutical depot; devices for
parenteral injection of pharmaceutical depot; devices for
injection of injection fluids; devices for injection of
injection depot; devices for subcutaneous administration of
pharmaceuticals; devices for parenteral administration of
pharmaceuticals; syringes for subcutaneous administration of
pharmaceuticals; syringes for parenteral administration of
pharmaceuticals; syringes for injection of pharmaceutical
depots; syringes for subcutaneous injection of
pharmaceutical depot; syringes for parenteral injection of
pharmaceutical depot; syringes for injection of injection
fluids; syringes for injection of injection depot; syringes
for injections; syringes for medical uses; pens for
subcutaneous administration of pharmaceuticals; pens for
parenteral administration of pharmaceuticals; pens for
injection of pharmaceutical depots; pens for subcutaneous
injection of pharmaceutical depot; pens for parenteral
injection of pharmaceutical depot; pens for injection of
injection fluids; pens for injection of injection depot;
pens for injections; pens for medical uses
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen